Biomarin Pharmaceutical Stock Price History
BMRN Stock | USD 92.06 2.57 2.87% |
If you're considering investing in Biomarin Stock, it is important to understand the factors that can impact its price. As of today, the current price of Biomarin Pharmaceutical stands at 92.06, as last reported on the 24th of April, with the highest price reaching 92.22 and the lowest price hitting 89.93 during the day. We consider Biomarin Pharmaceutical very steady. Biomarin Pharmaceutical secures Sharpe Ratio (or Efficiency) of 0.0174, which signifies that the company had a 0.0174% return per unit of risk over the last 3 months. We have found thirty technical indicators for Biomarin Pharmaceutical, which you can use to evaluate the volatility of the firm. Please confirm Biomarin Pharmaceutical's Mean Deviation of 0.9635, risk adjusted performance of 0.0158, and Downside Deviation of 1.19 to double-check if the risk estimate we provide is consistent with the expected return of 0.0216%.
Biomarin Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Biomarin |
Sharpe Ratio = 0.0174
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | BMRN |
Estimated Market Risk
1.24 actual daily | 10 90% of assets are more volatile |
Expected Return
0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Biomarin Pharmaceutical is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biomarin Pharmaceutical by adding it to a well-diversified portfolio.
Biomarin Pharmaceutical Stock Price History Chart
There are several ways to analyze Biomarin Stock price data. The simplest method is using a basic Biomarin candlestick price chart, which shows Biomarin Pharmaceutical price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | April 12, 2024 | 92.22 |
Lowest Price | March 18, 2024 | 83.81 |
Biomarin Pharmaceutical April 24, 2024 Stock Price Synopsis
Various analyses of Biomarin Pharmaceutical's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Biomarin Stock. It can be used to describe the percentage change in the price of Biomarin Pharmaceutical from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Biomarin Stock.Biomarin Pharmaceutical Price Daily Balance Of Power | 1.12 | |
Biomarin Pharmaceutical Price Action Indicator | 2.27 | |
Biomarin Pharmaceutical Price Rate Of Daily Change | 1.03 |
Biomarin Pharmaceutical April 24, 2024 Stock Price Analysis
Biomarin Stock Price History Data
The price series of Biomarin Pharmaceutical for the period between Thu, Jan 25, 2024 and Wed, Apr 24, 2024 has a statistical range of 8.41 with a coefficient of variation of 2.57. The prices are distributed with arithmetic mean of 88.1. The median price for the last 90 days is 88.15.Open | High | Low | Close | Volume | ||
04/24/2024 | 90.03 | 92.22 | 89.93 | 92.06 | ||
04/23/2024 | 90.03 | 92.22 | 89.93 | 92.06 | 1,299,078 | |
04/22/2024 | 89.46 | 89.81 | 88.89 | 89.49 | 1,257,348 | |
04/19/2024 | 89.67 | 90.18 | 88.29 | 88.63 | 1,778,607 | |
04/18/2024 | 90.25 | 91.21 | 89.78 | 90.07 | 944,850 | |
04/17/2024 | 91.14 | 91.53 | 90.02 | 90.47 | 1,282,481 | |
04/16/2024 | 90.93 | 91.78 | 90.16 | 90.87 | 1,235,787 | |
04/15/2024 | 92.58 | 93.36 | 90.96 | 91.51 | 1,942,193 | |
04/12/2024 | 91.26 | 93.26 | 91.09 | 92.22 | 2,419,825 | |
04/11/2024 | 90.99 | 91.59 | 89.33 | 91.46 | 2,296,903 | |
04/10/2024 | 88.38 | 90.41 | 87.79 | 90.21 | 2,204,505 | |
04/09/2024 | 87.35 | 89.19 | 87.35 | 88.98 | 1,178,105 | |
04/08/2024 | 87.00 | 88.11 | 86.95 | 87.28 | 1,344,968 | |
04/05/2024 | 86.46 | 87.23 | 86.01 | 86.95 | 828,855 | |
04/04/2024 | 86.78 | 88.13 | 86.63 | 86.89 | 1,151,883 | |
04/03/2024 | 86.48 | 87.72 | 86.48 | 86.78 | 1,166,479 | |
04/02/2024 | 86.25 | 86.94 | 85.62 | 86.80 | 1,410,588 | |
04/01/2024 | 86.98 | 87.31 | 86.09 | 87.10 | 715,532 | |
03/28/2024 | 88.34 | 88.66 | 86.65 | 87.34 | 1,027,708 | |
03/27/2024 | 88.18 | 88.74 | 87.92 | 88.61 | 1,031,697 | |
03/26/2024 | 86.94 | 87.86 | 86.50 | 87.74 | 1,346,939 | |
03/25/2024 | 84.70 | 86.99 | 84.70 | 86.52 | 1,409,254 | |
03/22/2024 | 84.35 | 85.29 | 83.90 | 85.13 | 876,720 | |
03/21/2024 | 84.99 | 85.25 | 83.84 | 84.11 | 919,107 | |
03/20/2024 | 85.01 | 85.19 | 83.82 | 84.76 | 879,941 | |
03/19/2024 | 84.43 | 85.60 | 83.77 | 85.27 | 1,300,210 | |
03/18/2024 | 84.13 | 84.67 | 83.66 | 83.81 | 1,404,481 | |
03/15/2024 | 84.56 | 84.75 | 83.44 | 83.87 | 1,185,802 | |
03/14/2024 | 84.61 | 84.94 | 83.53 | 84.39 | 1,244,299 | |
03/13/2024 | 85.19 | 85.71 | 84.57 | 84.77 | 1,312,690 | |
03/12/2024 | 86.27 | 86.69 | 84.87 | 85.18 | 1,027,892 | |
03/11/2024 | 85.69 | 86.82 | 85.53 | 86.00 | 1,368,855 | |
03/08/2024 | 85.90 | 86.55 | 85.70 | 85.95 | 1,252,138 | |
03/07/2024 | 87.21 | 87.87 | 85.63 | 85.89 | 1,224,150 | |
03/06/2024 | 87.25 | 87.60 | 86.11 | 86.77 | 1,007,066 | |
03/05/2024 | 87.09 | 87.42 | 85.01 | 86.02 | 1,710,509 | |
03/04/2024 | 87.57 | 87.92 | 86.51 | 87.72 | 800,734 | |
03/01/2024 | 86.39 | 88.28 | 85.88 | 87.14 | 1,927,864 | |
02/29/2024 | 88.80 | 89.00 | 86.02 | 86.28 | 2,604,479 | |
02/28/2024 | 89.82 | 90.28 | 88.32 | 88.40 | 1,172,821 | |
02/27/2024 | 90.64 | 92.16 | 90.06 | 90.68 | 1,249,147 | |
02/26/2024 | 90.93 | 91.23 | 88.11 | 90.10 | 1,470,158 | |
02/23/2024 | 90.94 | 94.15 | 89.48 | 91.24 | 3,652,648 | |
02/22/2024 | 89.30 | 90.50 | 88.63 | 89.97 | 1,652,683 | |
02/21/2024 | 88.67 | 89.20 | 87.40 | 88.54 | 1,268,429 | |
02/20/2024 | 88.14 | 90.26 | 87.53 | 88.67 | 1,859,731 | |
02/16/2024 | 88.30 | 89.49 | 87.85 | 88.77 | 1,054,480 | |
02/15/2024 | 86.11 | 88.73 | 85.97 | 88.30 | 1,990,541 | |
02/14/2024 | 86.24 | 86.81 | 85.71 | 86.01 | 1,233,336 | |
02/13/2024 | 87.15 | 87.39 | 85.60 | 86.13 | 925,484 | |
02/12/2024 | 88.47 | 89.16 | 88.10 | 88.18 | 1,279,650 | |
02/09/2024 | 88.28 | 88.64 | 87.83 | 88.46 | 1,355,301 | |
02/08/2024 | 89.77 | 90.18 | 87.43 | 88.15 | 1,140,939 | |
02/07/2024 | 89.46 | 91.06 | 88.41 | 89.66 | 2,851,101 | |
02/06/2024 | 88.12 | 90.05 | 87.49 | 89.80 | 1,608,956 | |
02/05/2024 | 87.76 | 88.33 | 87.08 | 87.72 | 1,133,273 | |
02/02/2024 | 87.91 | 88.43 | 87.29 | 88.11 | 1,396,296 | |
02/01/2024 | 87.72 | 88.87 | 87.26 | 88.74 | 1,429,543 | |
01/31/2024 | 89.67 | 90.01 | 87.63 | 88.08 | 1,121,492 | |
01/30/2024 | 91.59 | 91.59 | 89.43 | 89.62 | 1,675,898 | |
01/29/2024 | 91.00 | 91.78 | 89.46 | 91.78 | 691,154 |
About Biomarin Pharmaceutical Stock history
Biomarin Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Biomarin is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Biomarin Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Biomarin Pharmaceutical stock prices may prove useful in developing a viable investing in Biomarin Pharmaceutical
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. The company was incorporated in 1996 and is headquartered in San Rafael, California. Biomarin Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3045 people.
Biomarin Pharmaceutical Stock Technical Analysis
Biomarin Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
All Next | Launch Module |
Biomarin Pharmaceutical Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Biomarin Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of Biomarin Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Biomarin to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0158 | |||
Jensen Alpha | 0.0141 | |||
Total Risk Alpha | (0.16) | |||
Sortino Ratio | (0.06) | |||
Treynor Ratio | (0.39) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomarin Pharmaceutical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Biomarin Stock, please use our How to Invest in Biomarin Pharmaceutical guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Biomarin Stock analysis
When running Biomarin Pharmaceutical's price analysis, check to measure Biomarin Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomarin Pharmaceutical is operating at the current time. Most of Biomarin Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Biomarin Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomarin Pharmaceutical's price. Additionally, you may evaluate how the addition of Biomarin Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is Biomarin Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomarin Pharmaceutical. If investors know Biomarin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomarin Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biomarin Pharmaceutical is measured differently than its book value, which is the value of Biomarin that is recorded on the company's balance sheet. Investors also form their own opinion of Biomarin Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biomarin Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomarin Pharmaceutical's market value can be influenced by many factors that don't directly affect Biomarin Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomarin Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomarin Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomarin Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.